Brightspring Health Services Inc
NASDAQ:BTSG
Relative Value
There is not enough data to reliably calculate the relative value of BTSG.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
BTSG Competitors Multiples
Brightspring Health Services Inc Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Brightspring Health Services Inc
NASDAQ:BTSG
|
7.9B USD | 0 | 0 | 0 | 0 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
96.4B USD | 0.2 | 54.6 | 13.9 | 13.9 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
66.4B EUR | 0.3 | 12.9 | 7.6 | 9.7 | |
| US |
|
Cigna Corp
NYSE:CI
|
68.4B USD | 0.2 | 11.5 | 0 | 0 | |
| DE |
|
Fresenius SE & Co KGaA
XETRA:FRE
|
26.8B EUR | 1.2 | 21.2 | 9.9 | 14.7 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
23.4B EUR | 1.2 | 23.9 | 9.2 | 17 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
22B USD | 2 | 22.4 | 12.4 | 16.8 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
22.2B USD | 1.6 | 25.4 | 12.2 | 17.7 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
11B EUR | 0.6 | 11.2 | 5.4 | 9.9 | |
| US |
|
Guardant Health Inc
NASDAQ:GH
|
11.8B USD | 11.7 | -27.7 | -29.8 | -27.1 | |
| US |
|
DaVita Inc
NYSE:DVA
|
10.3B USD | 0.8 | 14 | 7.3 | 9.9 |